{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-083088","form_type":"8-K","ticker":"CGON","cik":"0001991792","company_name":"CG Oncology, Inc.","filed_at":"2025-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.649996+00:00","generated_at":"2026-05-19T18:47:33.317275+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"CG Oncology stockholders elect three Class I directors, ratify EY as auditor at 2025 annual meeting","bullets":["Arthur Kuan, James J. Mulé, Leonard Post elected as Class I directors to serve until 2028 annual meeting.","Ratification of Ernst & Young as independent auditor for fiscal year ending Dec 31, 2025 was approved with 69.7M votes for, 7K against.","Broker non-votes of 8.45M shares on director elections; no broker non-votes on auditor ratification."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-083088","json":"https://secwatch.observer/filing/0000950170-25-083088.json","markdown":"https://secwatch.observer/filing/0000950170-25-083088.md","text":"https://secwatch.observer/filing/0000950170-25-083088.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1991792/000095017025083088/0000950170-25-083088-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1991792/000095017025083088/ck0001991792-20250605.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T18:47:33.317275+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}